Armata Pharmaceuticals (ARMP) Expected to Announce Quarterly Earnings on Tuesday

Armata Pharmaceuticals (NYSEAMERICAN:ARMP) is projected to issue its quarterly earnings data before the market opens on Tuesday, May 6th. Analysts expect the company to announce earnings of ($0.38) per share and revenue of $1.38 million for the quarter.

Armata Pharmaceuticals Stock Performance

Shares of ARMP stock opened at $1.44 on Friday. Armata Pharmaceuticals has a one year low of $0.90 and a one year high of $3.45. The business has a fifty day moving average price of $1.47. The company has a market capitalization of $51.99 million, a PE ratio of -0.88 and a beta of 0.87.

About Armata Pharmaceuticals

Armata Pharmaceuticals, Inc, a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia.